Astera Labs surges as RBC lifts target to $250 on AWS Trainium3, Scorpio-X ramp

ALABALAB

Astera Labs shares jumped about 8.8% as RBC Capital raised its price target to $250 from $225 and reiterated an Outperform rating. The call highlights expected upside tied to AWS Trainium3-driven demand for Astera’s Scorpio-X connectivity platform starting in 2H 2026.

1) What’s moving ALAB today

Astera Labs (ALAB) is higher today after RBC Capital raised its price target to $250 from $225 and maintained an Outperform rating. The note points to expanding revenue opportunity tied to AWS’s next-generation AI accelerator roadmap, with Trainium3 expected to be a key driver of Scorpio-X revenue beginning in the second half of 2026. (streetinsider.com)

2) The bull case investors are re-pricing

The thesis centers on Astera’s positioning in the infrastructure “plumbing” behind rack-scale AI—high-speed connectivity and data movement that becomes more critical as accelerators scale. RBC’s commentary specifically links AWS Trainium3 to incremental Scorpio-X demand, reinforcing expectations that 2026 growth can extend beyond prior assumptions as hyperscaler deployments broaden. (streetinsider.com)

3) What to watch next

With the stock reacting to forward-looking demand signals rather than a fresh company earnings release, investors will likely focus on (1) any additional analyst estimate revisions, (2) evidence of hyperscaler ramps heading into the back half of 2026, and (3) management’s next update on timing for Scorpio platform revenue inflection. The next scheduled earnings report is listed for May 5, 2026, which could be the next major catalyst to validate the ramp narrative. (investing.com)